Fig. 5From: Evaluating the clinical impact of routine whole genome sequencing in tuberculosis treatment decisions and the issue of isoniazid mono-resistanceSummary of 8 cases that required drug treatment changes that were not related to WGS results. These included 3 cases of drug induced liver injury, 2 cases of ethambutol toxicity, 1 case of pyrazinamide rash, 1 case of non-compliance and a case where drug alterations were made for clinical reasonsBack to article page